Clausen-Sjöbom N, Lins P E, Adamson U, Curstedt T, Hamberger B
Acta Med Scand. 1987;222(1):57-63. doi: 10.1111/j.0954-6820.1987.tb09929.x.
The effect of metoprolol on the counter-regulation of prolonged hypoglycemia was studied in eight insulin-dependent diabetics. Insulin was given as an i.v. infusion of 2.4 U/h over 180 min alone, or together with metoprolol (3.0 mg i.v. bolus followed by an i.v. infusion of 4.8 mg/h) in random order. Blood glucose, counter-regulatory hormones, hypoglycemic symptoms and the cardiovascular responses were assayed over 240 min. Metoprolol did not significantly modify the blood glucose levels. The plasma levels of free insulin, however, were elevated by approximately 20% (p less than 0.01) by metoprolol during hypoglycemia and the plasma concentrations of epinephrine, norepinephrine, growth hormone and cortisol were enhanced by the drug. Sweating was increased by metoprolol, while other symptoms were unaltered. We conclude that metoprolol administered acutely does not aggravate prolonged hypoglycemia in diabetics with blunted response of glucagon. Moreover, exaggerated responses of counter-regulatory hormones, provoked by metoprolol, may compensate for the inhibitory effect of this drug on insulin clearance.
在8名胰岛素依赖型糖尿病患者中研究了美托洛尔对长时间低血糖反调节的影响。单独静脉输注胰岛素2.4 U/h,持续180分钟,或以随机顺序同时给予美托洛尔(静脉推注3.0 mg,随后静脉输注4.8 mg/h)。在240分钟内测定血糖、反调节激素、低血糖症状和心血管反应。美托洛尔未显著改变血糖水平。然而,在低血糖期间,美托洛尔使游离胰岛素的血浆水平升高了约20%(p<0.01),且该药物使肾上腺素、去甲肾上腺素、生长激素和皮质醇的血浆浓度升高。美托洛尔使出汗增加,而其他症状未改变。我们得出结论,急性给予美托洛尔不会加重胰高血糖素反应迟钝的糖尿病患者的长时间低血糖。此外,美托洛尔引发的反调节激素的过度反应可能会弥补该药物对胰岛素清除的抑制作用。